Genome Editing Market is Generating Revenue of $36.06 Billion by 2030, at CAGR 22.3% Growth Rate

Growth of the genome editing market is driven by increase in adoption of genome editing applications. Moreover, development of CRISPR-based novel diagnostic tools to mitigate the adverse impact of the COVID-19 pandemic also boost the genome editing market growth

The global genome editing industry accounted for $4.81 billion in 2020, and is expected to reach $36.06 billion in 2030, growing at a CAGR of 22.3% from 2021 to 2030.

Rise in adoption of genome editing applications, expansion in pervasiveness of disease and other genetic disorders, accessibility of government financing and development in genomics projects, and mechanical headways in gene-editing tools drive the development of the global genome editing market. Nonetheless, moral issues with respect to genome editing prevent the market development. Actually, presence of significant market major parts in agricultural nations and application in different medication revelation measures are relied upon to open rewarding open doors later on.

Request Sample Report at:

Covid-19 scenario:

  • The covid-19 pandemic disrupted workflow in the healthcare sector. The spread of diseases forced several industries to close their facilities including sub-domains of healthcare.
  • On the other hand, optimum utilization of the workforce and gene editing for human benefit are some of the challenges that researchers face. Thus, CRISPR-based diagnostic tools to reduce the impact of the Covid-19 gained importance.
  • However, the use of CRISPR was favored during the pandemic and technologies based on naturally occurring bacterial gene-editing systems played a vital role to come up with the best defense against Covid-19.

The report offers detailed segmentation of the global genome editing market based on technology, end user, and region.

Based on technology, the CRISPR segment accounted for the largest share of the genome editing market in 2020. The large share of this segment can be attributed to the ease of use associated with CRISPR, which gives it a significant advantage over ZFN and TALEN.

By end user, the biotechnology & pharma companies segment accounted for the largest share of the genome editing market in 2020. The increasing prevalence of infectious diseases and cancer is driving research activities worldwide. This is expected to drive the demand for genome editing in biotechnology & pharmaceutical companies.

By region, the global genome editing market across North America held the largest share in 2020, contributing to nearly half of the market. This growth is due to development of gene therapy in the U.S., surge in use of genetically modified crops, and increase in prevalence of infectious diseases coupled with availability of research grants and funding. However, the market across Asia-Pacific is expected to register the highest CAGR of 25.2% during the forecast period, owing to rise in funding for genome editing and medical genetics in developing countries in the region.

Access Full Report:

The Major Key Players Are:

Agilent Technologies, CRISPR Therapeutics, Danaher, Eurofins Scientific, Editas Medicine, GenScript, Horizon Discovery Limited, Lonza, Merck and Thermo Fisher Scientific.

Trending Reports:

Blood Purification Equipment Market - Global Opportunity Analysis and Industry Forecast, 2021–2030

Wearable Patch Market - Global Opportunity Analysis and Industry Forecast, 2021–2030

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.


David Correa

5933 NE Win Sivers Drive

#205, Portland, OR 97220

United States

USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141

UK: +44-845-528-1300

Hong Kong: +852-301-84916

India (Pune): +91-20-66346060

Fax: +1(855)550-5975

help@alliedmarketresearch (dot) com

Back to news